February 28, 2019 by coryshubert MM In The News – Drugs Multiple Myeloma, News Leave a comment I guess 26.2% of effectiveness isn’t enough to move forward, but at least they are trying. FDA Panel Punts on Selinexor for Multiple Myeloma Majority say approval decision should wait for ongoing trial results Read it here Share this:Share Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Like Loading...
My Smoldering Life 